USA-based nonprofit CureDuchenne has announced the appointment of Brenda Wong as its new chief medical advisor (CMA), ...

South Korean Samsung Group’s biopharmaceutical business is being reorganized into two separate tracks: contract development ...

The US Food and Drug Administration is continuing to take steps to help state importation programs provide safe, effective ...

Chinese drugmaker Jiangsu Hengrui Pharmaceuticals priced its Hong Kong stock offering at the top of the marketed range to ...

Precision oncology start-up Fore Biotherapeutics, founded in 2011, today announced a $38 million Series D-2 financing.

US clinical-stage biotech Vigil Neuroscience (Nasdaq: VIGL) saw its share price skyrocket more than 240% to $7.89 pre-market, on the news that French pharma major Sanofi (Euronext: SAN) had made a ...

USA-based UroGen Pharma, a biotech developing and commercializing innovative solutions that treat urothelial and specialty ...

UK pharma major AstraZeneca (LSE: AZN) is set to present data from more than 80 studies at the 2025 American Society of ...

Privately-held US genome-scale drug discovery company Orionis Biosciences has announced a second multi-year collaboration ...

Swiss biosimilars specialist Sandoz (SIX: SDZ) has launched what it says is the first autoinjector presentation of a biosimilar to Stelara (ustekinumab) in Europe, bolstering its presence in the ...

Merck KGaA (MRK: DE) plans to move its investigational lupus drug enpatoran into late-stage development, after new Phase II data showed clinically meaningful improvement in skin manifestations of the ...

The share of generics in the Russian pharmaceutical market is steadily growing despite the efforts of the local state to ...